Relative Contributions of 5-Hydroxytryptamine (5-HT) Receptor Subtypes in 5-HT-Induced Vasoconstriction of the Distended Human Saphenous Vein as a Coronary Artery Bypass Graft
-
- Nakamura Eisaku
- Department of Cardiovascular Surgery, Miyazaki Prefectural Nobeoka Hospital
-
- Tanaka Naoko
- First Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare
-
- Kuwabara Masachika
- Kuwabara Clinic
-
- Yamashita Atsushi
- First Department of Pathology, Faculty of Medicine, Miyazaki University
-
- Matsuo Yasuko
- First Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare
-
- Kanai Tasuku
- First Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare
-
- Onitsuka Toshio
- Department of Thoracic and General Surgery, Faculty of Medicine, Miyazaki University
-
- Asada Yujiro
- First Department of Pathology, Faculty of Medicine, Miyazaki University
-
- Hisa Hiroaki
- Second Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare
-
- Yamamoto Ryuichi
- First Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare
この論文をさがす
抄録
It is established that the segment of saphenous vein (SV) that is widely used as a conduit vessel in coronary artery bypass graft (CABG) surgery is distended with high pressure to check for leaks and to increase the patency before implantation into coronary arterial circulation. The aim of the present study was to elucidate the relative contributions of 5-hydroxytryptamine (5-HT) receptor subtypes responsible for 5-HT-induced vasoconstriction of the distended human SV. Whereas about half of the 5-HT-induced vasoconstriction still remained in the presence of supramaximum concentration of sarpogrelate or of SB224289 (5-HT2A and 5-HT1B receptor antagonists, respectively), simultaneous treatment with sarpogrelate and SB224289 almost completely inhibited the 5-HT-induced vasoconstriction. Immunopositive staining for 5-HT2A and 5-HT1B receptors was detected in smooth muscle cells of the distended human SV and there was no significant difference between the immunopositive areas of 5-HT2A and 5-HT1B receptors. These results demonstrate that 5-HT2A and 5-HT1B receptors similarly contribute to 5-HT-induced vasoconstriction in human distended SV. Thus, when the SV is used as a CABG conduit, a combination of 5-HT2A and 5-HT1B receptor antagonists would appear to be most useful to prevent 5-HT-induced spasm.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 34 (1), 82-86, 2011
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679602778752
-
- NII論文ID
- 130000402267
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 10926830
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可